Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial

Acta Oncol. 2023 Dec;62(12):1973-1978. doi: 10.1080/0284186X.2023.2273898. Epub 2023 Nov 25.
No abstract available

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Multicenter Studies as Topic
  • Pancreas / pathology
  • Pancreatic Neoplasms* / drug therapy
  • Pancreatic Neoplasms* / pathology
  • Patient Preference*
  • Prospective Studies